Not FDA-approved
Digestive & weight
BPC-157
Evidence
Mostly animal studies
Class
Synthetic fragment of a gastric protein
KEY TAKEAWAY
BPC-157 is a 15-amino-acid synthetic peptide studied mainly in rodents for tissue and gut healing. Human trial data are very limited and it is not approved by the FDA.
Written by the Veylo editorial team · Updated
November 2026
What it is
A synthetic peptide derived from a stomach protein
Studied for
Tendon, muscle and gut healing in animal models
Key fact
Reported faster healing in rodent injury and gut models; human data are scarce
Route
Injection or oral (research use)
Evidence strength
Mostly animal studies
BPC-157, short for body protection compound, is a lab-made peptide modeled on a fragment of a protein found in gastric juice.
Animal studies suggest it may influence blood vessel growth, growth factor signaling and inflammation. The exact mechanism has not been confirmed in people.
BPC-157 is not approved by the FDA for any use and is on the World Anti-Doping Agency prohibited list. The FDA has flagged it among substances that raise safety questions for compounding.
Studied in animals for tendon, ligament, muscle and gastrointestinal injury. It has no approved medical use.
Human safety data are limited to very small studies. Because it has not been tested in large trials, the full range of risks is unknown.
Primary literature for this entry is being compiled.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.